How The Kura Oncology (KURA) Story Is Shifting With Komzifti And New Street Targets [Yahoo! Finance]
Kura Oncology, Inc. (KURA)
Last kura oncology, inc. earnings: 2/25 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.kuraoncology.com/investor-relations
Company Research
Source: Yahoo! Finance
Kura Oncology's fair value estimate has been adjusted slightly, with the price target moving from US$33.00 to US$32.45. This tweak reflects a mix of upbeat and cautious Street views as analysts react to Komzifti's early launch feedback, Q4 updates, and management guidance that have led to both higher and lower targets across the range. As you read on, you will see how these shifting targets fit into the broader analyst narrative and what to watch to stay on top of the story. Stay updated as the Fair Value for Kura Oncology shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Kura Oncology. What Wall Street Has Been Saying ?? Bullish Takeaways BofA nudged its target to US$30 from US$29 after Q4, pointing to Komzifti launch feedback that it viewed positively, with comments that recent updates strengthen the story in its view. Wedbush kept an Outperform rating and a higher target of US$36, explicitly stating
Show less
Read more
Impact Snapshot
Event Time:
KURA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
KURA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
KURA alerts
High impacting Kura Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
KURA
News
- Kura Oncology (KURA) had its "buy" rating reaffirmed by UBS Group AG.MarketBeat
- Kura Oncology, Inc. (KURA) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Kura Oncology (KURA) had its price target lowered by Wedbush from $38.00 to $36.00. They now have an "outperform" rating on the stock.MarketBeat
- Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)GlobeNewswire
- Kura Oncology Inc (KURA) Q4 2025 Earnings Call Highlights: KOMZIFTI Launch Boosts Revenue Amid ... [Yahoo! Finance]Yahoo! Finance
KURA
Earnings
- 3/5/26 - Miss
KURA
Sec Filings
- 3/5/26 - Form 10-K
- 3/5/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- KURA's page on the SEC website